Search clinical trials for: ATLCAR.CD30

Total 7 results

  • UNC Lineberger Comprehensive Cancer Center
    Not yet recruiting
    ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
    Hodgkin Lymphoma | Relapse | Refractory
    United States
  • UNC Lineberger Comprehensive Cancer Center
    No longer available
    Compassionate Use Re-Infusion of ATLCAR.CD30
    Hodgkin Lymphoma, Adult
    United States
  • UNC Lineberger Comprehensive Cancer Center
    National Heart, Lung, and Blood Institute (NHLBI)
    Active, not recruiting
    Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
    Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Hodgkin Disease
    United States
  • UNC Lineberger Comprehensive Cancer Center
    University Cancer Research Fund at Lineberger Comprehensive Cancer Center
    Recruiting
    CD30 CAR for CD30+ NSGCT
    Nonseminomatous Germ Cell Tumor | Germ Cell Tumor
    United States
  • UNC Lineberger Comprehensive Cancer Center
    Recruiting
    Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
    Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin
    United States
  • UNC Lineberger Comprehensive Cancer Center
    Stand Up To Cancer; University Cancer Research Fund at Lineberger Comprehensive...
    Recruiting
    Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
    Neoplasms | Immune System Diseases | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Mycosis Fungoides | Sezary Syndrome | Cutaneous T Cell Lymphoma | Gray Zone Lymphoma | Cutaneous Lymphoma | Lymphomatoid Papulosis | Cutaneous Anaplastic Large Cell Lymphoma
    United States
  • UNC Lineberger Comprehensive Cancer Center
    Recruiting
    CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
    Peripheral T Cell Lymphoma
    United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe